Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 12 November 2020

 
 
 
   

Can the pharmaceutical industry be more transparent?

 
The EFPIA Podcast Series

With COVID-19 dominating the attention of the world's media, there is more interest than ever in how the pharmaceutical industry works.

Today we’re asking Andy Powrie-Smith, Executive Director of Communications & Partnerships at EFPIA "Can the industry be more transparent?" 


Read more


 
 
 
   

Statements

 

EFPIA statement on Building a European Health Union: preparedness and resilience
11 November 2020

EFPIA welcomes the proposals from the Commission to strengthen the resilience and preparedness of Europe against serious... Read more

Joint EU-UK pharmaceutical industry response to Specialised Committee outcome
06 November 2020

We are pleased the UK Government and EU Commission have responded to the concerns raised by industry and removed the... Read more

 
 
 
   

Blogs

 

IMI Impact: transforming the lives of children (Guest blog)
06 November 2020 - Heidrun Hildebrand

The Innovative Medicines Initiative is making a difference to children living with paediatric diseases Read more

Let’s talk about NETs: World NET Cancer Day (Guest blog)
10 November 2020 - Jose Amauri Soares

Early diagnosis is critical to improving outcomes, however for many living with neuroendocrine tumors (NETs), diagnosis... Read more

Let's talk about NETs (Guest blog)
10 November 2020 - Catherine Bouvier

“If you don’t suspect it you can’t detect it” – awareness and education are the key Read more

Why we need increased healthcare spending in Central and Eastern Europe (Guest blog)
12 November 2020 - Gabriele Grom

Countries in Central and Eastern Europe initially weathered the effects of the COVID-19 pandemic, but their vulnerability... Read more

 
 
 
   

Videos

 

EFPIA symposium at the 30th Alzheimer Europe Conference
It is time for European healthcare systems to prepare for Alzheimer’s breakthroughs Read more

Orphan Medicines: how to sustain innovation in an area of high unmet need?
Watch our latest virtual event on orphan medicines. Read more

 
 
 
   

Events

 

POLITICO's Health Care Summit
17 November 2020 (Virtual event)

Join the many thought-provoking discussions on November 17-18, where you'll be able to debate the biggest EU health... Read more

Designing Tomorrow’s Healthcare Systems
17 November 2020 (Virtual event)

EU-Russia Healthcare conference, with the support of the World Health Organization Read more

From silo budgeting to financial integration: Where does the EU stand in diabetes care?
20 November 2020 (Online event)

Lessons learned from an EFPIA/The Economist Intelligence Unit study Read more

34th International Conference of Alzheimer’s Disease International
10 December 2020 (Virtual event)

Hope in the Age of Dementia New science. New knowledge. New solutions. Read more

 
 
 
   

Our latest publications

 

Alzheimer’s Disease Health System Readiness – The Time to Act is Now
21 September 2020 (Publications)

We are at a turning point in our fight against dementia and Alzheimer’s disease. Long-awaited new therapies are on the... Read more

 
 
 
   

What we are reading

 

Europe needs to give EU Orphan Drugs regulation more time to show its effectiveness
On 12 November 2020 (Euractiv)

This article is part of the EFPIA special report for Euractiv. Read more

Valuing vaccines
On 12 November 2020 (ABPI)

Medicines and vaccines developed by the pharmaceutical industry are transforming the lives of millions of people, every... Read more

The vaccine industry – meeting the challenges of COVID-19
On 05 November 2020 (Health Europa)

Magdalena Rodriguez de Azero, Executive Director Vaccines Europe, discusses issues around vaccine provision, including... Read more

It is time for European health care systems to prepare for Alzheimer’s breakthroughs
On 21 September 2020 (Politico)

New dementia medicines are coming, but Europe needs an ambitious plan to prepare for them. Read more